Shareholder plans $15,043,390 BSX (NYSE: BSX) stock sale

Rhea-AI Filing Summary

A shareholder of BSX filed a notice of proposed sale of 160,901 shares of common stock, with an aggregate market value of $15,043,390.17. The planned sales are to be executed through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 02/02/2026.

The shares to be sold were acquired through a mix of performance shares, restricted stock, and a stock option exercise, all obtained directly from the issuer between 2018 and 2026, with the stock option portion paid in cash.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	160901	15043390.17	1482442039	02/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/31/2024	Performance Shares	ISSUER			31465	12/31/2024	Not Applicable
Common	02/22/2018	Restricted Stock	ISSUER			6598	02/22/2018	Not Applicable
Common	02/02/2026	Stock Option Exercise	ISSUER			95754	02/02/2026	Cash
Common	02/16/2023	Restricted Stock	ISSUER			9050	02/16/2023	Not Applicable
Common	02/23/2018	Restricted Stock	ISSUER			1896	02/23/2018	Not Applicable
Common	02/24/2018	Restricted Stock	ISSUER			16138	02/24/2018	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many BSX shares are planned for sale under this Form 144 filing?

The filing covers a proposed sale of 160,901 shares of BSX common stock. These shares are listed with an aggregate market value of $15,043,390.17, based on the market information included in the notice.

What is the aggregate market value of BSX shares to be sold?

The planned sale has an aggregate market value of $15,043,390.17. This value is calculated for the 160,901 common shares listed in the notice and reflects the market pricing assumptions disclosed in the filing.

Which broker will handle the BSX share sale disclosed in this Form 144?

The proposed sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s office is listed at 1 New York Plaza, 8th Floor, New York, NY 10004, and the shares are expected to be sold on the NYSE.

When is the approximate sale date for the BSX shares in this notice?

The approximate sale date for the BSX common shares is listed as 02/02/2026. This date represents when the filer expects to begin selling the 160,901 shares through the broker named in the Form 144 filing.

How were the BSX shares in this Form 144 acquired by the seller?

The shares were acquired directly from the issuer through performance shares, multiple grants of restricted stock, and a stock option exercise. Acquisition dates range from 02/22/2018 to 02/02/2026, with the stock option exercise paid in cash.

On which exchange are the BSX shares in this Form 144 planned to be sold?

The filing states that the BSX common shares are planned to be sold on the New York Stock Exchange (NYSE). The transaction will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services as the designated broker.